Compare · ILMN vs OSCR
ILMN vs OSCR
Side-by-side comparison of Illumina Inc. (ILMN) and Oscar Health Inc. (OSCR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ILMN and OSCR operate in Medical Specialities (Health Care), so they compete in similar markets.
- ILMN is the larger of the two at $40.46B, about 3.9x OSCR ($10.33B).
- Over the past year, ILMN is up 174.9% and OSCR is up 64.6% - ILMN leads by 110.3 points.
- ILMN has been more active in the news (8 items in the past 4 weeks vs 5 for OSCR).
- Both have 25 recent analyst ratings on file.
- Company
- Illumina Inc.
- Oscar Health Inc.
- Price
- $262.52-2.06%
- $31.89-4.72%
- Market cap
- $40.46B
- $10.33B
- 1M return
- +7.01%
- -0.25%
- 1Y return
- +174.89%
- +64.55%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2000
- 2021
- News (4w)
- 8
- 5
- Recent ratings
- 25
- 25
Illumina Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Oscar Health Inc.
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a full stack technology platform. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was founded in 2012 and is headquartered in New York, New York.
Latest ILMN
- Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs
- SEC Form 8-K filed by Illumina Inc.
- Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026
- Illumina releases SpliceAI2 to help advance rare disease research
- SEC Form 4 filed by Illumina Inc.
- SEC Form SCHEDULE 13G filed by Illumina Inc.
- Director Meister Keith A. was granted 107 shares, increasing direct ownership by 2% to 6,887 units (SEC Form 4)
- Director Ullem Scott B. was granted 113 shares, increasing direct ownership by 1% to 11,143 units (SEC Form 4)
- Chief Legal Officer Coletti Julie Ann was granted 18,763 shares (SEC Form 4)
- SVP, Chief Technology Officer Barnard Steven covered exercise/tax liability with 408 shares, decreasing direct ownership by 0.99% to 40,927 units (SEC Form 4)
Latest OSCR
- SEC Form 4 filed by Oscar Health Inc.
- SEC Form 4 filed by Oscar Health Inc.
- SEC Form 4 filed by Oscar Health Inc.
- Oscar Health, Inc. 2026 Third Quarter Earnings Conference Call
- Director Wittman Vanessa Ames sold $806,000 worth of shares (25,000 units at $32.24) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 112,121 units (SEC Form 4)
- Oscar Health Announces Thrive Capital’s Completion of Oscar Health Common Stock Distribution to its Limited Partners
- Co-Founder and Vice Chairman Kushner Joshua disposed of 12,687,234 shares and acquired 6,343,617 shares (SEC Form 4)
- Director Thrive Partners Ii Gp, Llc disposed of 12,687,234 shares and acquired 6,343,617 shares (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13D/A filed by Oscar Health Inc.
- SEC Form 144 filed by Oscar Health Inc.